BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets

Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...

November 21, 2024 | News

Singleron Biotechnologies Partners with TOMY Digital Biology to Expand Single Cell Analysis Solutions in Japan

Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Unde...

November 20, 2024 | News

Nxera Pharma Secures $3.5M Milestone as Centessa Pharmaceuticals Launches Phase 2 Trial of ORX750 for Sleep Disorders

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – notes t...

November 14, 2024 | News

Japan’s GHIT Fund Invests JPY 578 Million to Advance Diagnostics and Treatments for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 million (USD 4.0 million) in four projects ai...

November 07, 2024 | News

Inocras and Summit Pharmaceuticals Ink MOU to Transform Genomic Medicine in Japan

Inocras Inc. and Summit Pharmaceuticals International Corporation (“SPI”) signed an MOU (Memorandum of understanding) to jointly ex...

November 06, 2024 | News

Thermo Fisher Concludes Successful Bioprocess World Tour 2024 in APJ, Reigniting Industry Momentum Post-COVID

Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...

October 23, 2024 | News

Asahi Kasei Medical Launches Planova™ FG1: A Next-Generation Virus Removal Filter for Enhanced Biopharmaceutical Manufacturing

Asahi Kasei Medical, a global leader in virus removal solutions, proudly announces the launch of the Planova™ FG1, a next-generation virus removal fi...

October 23, 2024 | News

SONIRE Therapeutics Secures FDA Breakthrough Device Designation for Advanced HIFU Therapy in Pancreatic Cancer

SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (Hi...

October 17, 2024 | News

Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio

Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...

October 11, 2024 | News

Ciconia Bioventures Launched as Joint Venture to Drive Global Drug Discovery from Japan

Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, "Ciconia") announced its establishment as a joint venture compan...

October 09, 2024 | News

Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies

First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...

October 03, 2024 | News

Veltassa® Secures Approval in Japan for Hyperkalemia Management in CKD and Heart Failure Patients

Veltassa® offers effective and well-tolerated long-term potassium control in chronic kidney disease and chronic heart failure patients 1-5 Z...

September 25, 2024 | News

Axcelead Drug Discovery Partners and Acadia Pharmaceuticals Sign Master Service Agreement to Advance Novel Drug Discovery

Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; hereinafter referred to as “Axcelead DDP”) announced on September 10 tha...

September 20, 2024 | News

Daiichi Sankyo and AstraZeneca’s Datopotamab Deruxtecan Shows Superior Progression-Free Survival in Biomarker-Positive NSCLC Patients

Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan demonstrated meaningfully greater magnitude of progression-free survival benefit in p...

September 09, 2024 | News

Stay Connected